News & insights

Precision Oncology

Precision oncology matches each patient with the therapy most likely to work, based on the molecular profile of their tumor. For molecular labs, that means turning somatic NGS data into reliable, actionable results: detecting SNVs, indels and CNVs, and assessing genomic signatures such as HRD, MSI and TMB that guide treatment decisions.

In this section, we share our latest articles on precision oncology: case studies from labs using SeqOne for somatic analysis, scientific insights on biomarkers like homologous recombination deficiency, and updates on how our platform helps teams deliver faster, clinically validated cancer reports.

Keeping Genomic Diagnoses on Track at St George's Hospital

How our Clinical Interpretation Services helped nearly 900 families receive timely genomic analysis, and what a six-year partnership tells us about the future of clinical genomics.

DiagAI Expands Beyond SNVs: AI-Powered Prioritization for Structural Variants and CNVs

Meet UP²-SV: a dedicated AI pathogenicity classifier for structural variants, trained on 65,000+ ClinVar SVs and validated on a clinical cohort with 97.6% sensitivity. AI-powered prioritization now spans the full variant spectrum.

Implementing a Scalable Automated CGP Workflow in Routine Clinical Practice

Sequencing at scale is solved. Consistent interpretation isn't. See how one university hospital modernized their solid tumor NGS workflow and validated it for routine clinical use.

The Spring 2026 Release is Here

Our most ambitious release yet. 72 features and improvements, all IVDR-certified from day one, so every advance reaches patients without delay..

The 30-Year Waiting Room: How One Spanish Hospital Ended a Genomic Odyssey

A Spanish hospital ended a patient's 30-year diagnostic odyssey by combining Agilent's advanced exome sequencing with SeqOne's AI platform, uncovering a rare DMD gene duplication that had eluded detection for decades.

DiagAI Captures 98% of Causal Variants Within 10 Candidates, Validated on 565 Genomics England WGS Cases

Validated on 565 Genomics England WGS cases, DiagAI achieves impressive performance, with full explainability and CE-IVD certification.

HRD Testing Belongs in the Clinic. Genekor Medical Is Proving It.

Genekor Medical, a Romanian diagnostics lab, uses SeqOne's platform to make HRD testing a routine clinical workflow. Using shallow whole genome sequencing and automated FASTQ-to-GIS analysis, they've cut complexity and costs, proving that reliable precision oncology testing is achievable for regional labs beyond major European hubs.

Beyond the Black Box: A Framework for Evaluating Clinical Bioinformatics Platforms in 2026

Genomic data is abundant. Interpreting it is the challenge faced by most modern labs today. Watch our webinar for a practical framework on choosing the right bioinformatics platform.

Powering the Future of Genomics: How Uppsala University Hospital and SeqOne are Revolutionizing Clinical Diagnostics

Revolutionizing clinical diagnostics: Uppsala University Hospital and SeqOne build a unified, future-proof genomics lab.

Beyond the Exome: How One Lab is Democratizing Whole Genome Sequencing in Eastern Europe

Decoding the whole genetic code: how one lab mastered Whole Genome Sequencing to deliver life-changing rare disease diagnoses.

Scaling Personalized Medicine: How AI-Powered Bioinformatics are Redefining NGS Analysis at Cerba Internacional

Spanish diagnostic leader Cerba Internacional used the AI-driven SeqOne platform to overcome NGS data bottlenecks.

SeqOne Launches SomaLBx and SomaMethyl: A Comprehensive In-House Solution for Oncology Liquid Biopsy

New integrated tools enable comprehensive liquid biopsy analysis, covering both somatic variants and epigenetic signatures in a single workflow.